science glp 1 ICYMI, named the development of glucagon-like peptide-1 (#GLP1) agonists and last year's discovery that these drugs can blunt obesity-associated health problems as the 2023 #BreakthroughOfTheYear. Learn more: https://t.co/RwIK5Kkg3E #BOTY The benefits of GLP-1 drugs
Description
10.1038/s41386-019-0531-4 Summary Keywords addiction, dependence, reward, dopamine, gutbrain axis, appetite regulation Citation Jerlhag E (2023) The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies
* 24.9 or less No 25.0 26.9 Case by case ** 27.0 29.9 Likely ** 30.0 or above Likely Find your BMI on the chart below to see if you're within the indicated range for Zepbound treatment
For personalized guidance from Dr
4 World Health Organization
